pharma · Multiple Myeloma · Renal Cell Cancer · CRVS
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a pharma organization headquartered in Burlingame, USA. It trades on NYSE under ticker CRVS. Primary therapeutic focus areas include Multiple Myeloma, Renal Cell Cancer, Covid-19, COVID-19, Non-
Burlingame, USA HQ
2014 Founded
48 Employees
Public company Type
CRVS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Burlingame, USA
- Founded
- 2014
- Employees
- 48
- Programs
- 9
- Drugs
- 4
- Patents
- 14
Soquelitinib
Phase 3 · small molecule · Peripheral T-Cell Lymphoma, Not Otherwise Specified
Soquelitinib for Peripheral T-Cell Lymphoma, Not Otherwise Specified is a Phase 3 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CPI-818-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Corvus Pharmaceuticals
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Status
- active
- Trials
- 1